Minimally invasive musculoskeletal ultrasound provides a fast, accurate diagnosis of rheumatic diseases, among other benefits, researchers said.
Minimally invasive musculoskeletal ultrasound provides a fast, accurate diagnosis of rheumatic diseases - plus better measurement of treatment success, reduced procedural pain, and improved patient satisfaction.
"With so many people affected by rheumatic diseases, including arthritis, a diagnostic tool such as MSUS that is minimally invasive and with little risk to patients is an important tool for rheumatologists," said Tim McAlindon, MD, of Tufts Medical Center in Boston, Mass., lead researcher for a study published online in Arthritis Care & Research.
McAlindon’s task force reviewed the literature for recommendations on the use of MSUS and found evidence for several applications. A few examples include:
• further investigation into articular pain, swelling, or mechanical symptoms without definitive diagnosis on clinical exam;
• further investigation of current or new inflammatory arthritis symptoms, shoulder pain or mechanical symptoms to evaluate underlying structural disorders, but not for adhesive capsulitis or as preparation for surgical intervention;
• and evaluation of the parotid and submandibular glands in suspected Sjögren's disease.
Researchers also found that MSUS could be used to guide articular and peri-articular aspiration or injection at sites that include the synovial, tenosynovial, bursal, peritendinous and perientheseal areas.
Despite the benefits noted, the authors noted that they did not evaluate the economic impact of the procedure. McAlindon concluded, "Further study of the cost-effectiveness and long-term outcomes of MSUS is necessary to determine its value compared to other interventions."
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which was unveiled at the American College of Cardiology (ACC) conference.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.